UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042569
Receipt number R000048521
Scientific Title Development of an artificial intelligence system using deep learning to indicate anatomical landmarks during laparoscopic gastrectomy
Date of disclosure of the study information 2020/11/26
Last modified on 2023/11/29 12:54:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of an artificial intelligence system using deep learning to indicate anatomical landmarks during laparoscopic gastrectomy

Acronym

Development of an artificial intelligence system using deep learning to indicate anatomical landmarks during laparoscopic gastrectomy

Scientific Title

Development of an artificial intelligence system using deep learning to indicate anatomical landmarks during laparoscopic gastrectomy

Scientific Title:Acronym

Development of an artificial intelligence system using deep learning to indicate anatomical landmarks during laparoscopic gastrectomy

Region

Japan


Condition

Condition

gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To develop artificial intelligence (AI) based intraoperative landmark teaching system for laparoscopic gastrectomy and confirm the function of the AI device.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

Accuracy of landmark detection

Key secondary outcomes

Operative time
Amount of blood loss
Conversion ratio to conventional surgery
Morbidity
Mortality


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Histologically proven gastric carcinoma.
2) Clinical Stage I to III gastric carcinoma according to the Japanese classification system.
3) Regardless of occupation and number of tumors.
4) Aged 20 to 85 years old.
6) PS (ECOG) 0 or 1.
7) Sufficient organ function.
8) Provided written informed consent.

Key exclusion criteria

1) Severe mental disease.
2) Continuous systemic steroid therapy.
3) History of myocardial infarction or unstable angina pectoris within 6 months.
4) Uncontrollable hypertension.
5) Uncontrollable diabetes mellitus or administration of insulin.
6) Severe respiratory disease requiring continuous oxygen therapy.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Masafumi
Middle name
Last name Inomata

Organization

Oita University Faculty of Medicine

Division name

Gastroenterological and Pediatric Surgery

Zip code

879-5593

Address

1-1 Idaigaoka, Hasama-machi, Yufu city, Oita

TEL

097-586-5843

Email

oitagps@oita-u.ac.jp


Public contact

Name of contact person

1st name Kosuke
Middle name
Last name Suzuki

Organization

Oita University Faculty of Medicine

Division name

Gastroenterological and Pediatric Surgery

Zip code

879-5593

Address

1-1 Idaigaoka, Hasama-machi, Yufu city, Oita

TEL

097-586-5843

Homepage URL

http://www.surgery1.med.oita-u.ac.jp

Email

kosuzuki@oita-u.ac.jp


Sponsor or person

Institute

Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine

Address

1-1 Idaigaoka, Hasama-machi, Yufu city, Oita

Tel

097-586-5843

Email

kosuzuki@oita-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大分大学医学部 消化器・小児外科


Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 08 Month 02 Day

Date of IRB

2020 Year 09 Month 17 Day

Anticipated trial start date

2020 Year 12 Month 01 Day

Last follow-up date

2024 Year 09 Month 30 Day

Date of closure to data entry

2025 Year 04 Month 30 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2020 Year 11 Month 26 Day

Last modified on

2023 Year 11 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048521


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name